Emerging biomarkers and techniques in prostate cancer diagnosis

Modern biomarkers in prostate cancer diagnosis - PMC

New biological markers, such as TMPRSS2-ERG fusion gene, and the non-coding RNA (PCA3) [6] or kallikrein included in basic PHI (prostate health index) or 4K ...

Emerging biomarkers in the diagnosis of prostate cancer - PMC

In this review, we also summarize new promising biomarkers, such as PSA glycoforms, TMPRSS2:ERG fusion gene, microRNAs, circulating tumor cells, ...

An Improved Prostate Cancer Biomarker Test May Help Men Avoid ...

The new MPS2 urine test, developed by researchers at the University of Michigan, screens for 18 genetic markers that are highly associated with ...

The promising role of new molecular biomarkers in prostate cancer

Indeed, the use of miRNAs as biomarkers in PCa has shown promising results for risk assessment, diagnosis, and prognosis. Implementation of ...

Liquid Biomarkers in Prostate Cancer Diagnosis

Emerging biomarkers, including non-coding RNAs, circulating tumor DNA, and prostate-specific antigen (PSA) glycosylation, offer valuable ...

Current and emerging tissue‐based molecular biomarkers for ...

Various tissue-based molecular biomarkers can be utilized in the diagnostic, prognostic, and predictive management of prostate cancer. According ...

Advances in Prostate Cancer Biomarkers and Probes

Early diagnosis of PCa is essential to improve the survival rate of patients. However, the occurrence and development of PCa is a complex biological process, ...

Emerging Biomarker-Guided Therapies in Prostate Cancer - MDPI

With the advancement of molecular sequencing techniques, genomic precision through the identification of potential treatment targets and predictive biomarkers ...

Emerging Biomarkers for the Diagnosis and Prognosis of Prostate ...

These markers include kallikrein-related peptidase 2 (KLK2), early prostate cancer antigen (EPCA), PCA3, hepsin, prostate stem cell antigen, and α-methylacyl- ...

New generation biomarkers for the detection of prostate cancer

PSA/human kallikrein-3 stayed the primary line and the most preferred symptomatic strategy and technique for the location as the standard technique. In 1994, ...

Emerging Molecular Biomarkers in Advanced Prostate Cancer

Tissue, liquid, and imaging-based biomarkers in prostate cancer hold great potential as biomarkers for response assessments, staging and early detection of ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Prostate specific antigen (PSA) monitoring and histopathological examination of tumor biopsies remain gold standards in PCa diagnostics. These clinical ...

Biomarkers for Prostate Cancer: From Diagnosis to Treatment - MDPI

The current diagnostic methods for PCa have various limitations that can lead to overdiagnoses and overtreatment [8]. For example, PSA testing, while aiding ...

Advancements in Biomarkers of Prostate Cancer: A Review

This review assesses a broad spectrum of diagnostic and prognostic biomarkers, many of which are incorporated into clinical guidelines, ...

Prostate cancer detection: achieving an optimal balance - Nature

[10] reviewed several emerging non-MRI imaging techniques for prostate cancer detection, including micro-ultrasound (micro-US), contrast- ...

Emerging biomarkers for non-invasive diagnosis and treatment of ...

Notably, liquid biopsies, particularly those based on circulating tumour DNA (ctDNA), have emerged as the most promising method for early, non-invasive cancer ...

Emerging biomarkers of prostate cancer (Review)

In the clinical setting, the best diagnostic accuracy is potentially obtained in the 'grey' zone in which the yield of the free-to-total PSA ...

Prostate cancer theragnostics biomarkers: An update

PSA is the only biomarker for prostate cancer diagnosis and prognosis that has been authorized by the U.S. Food and Drug Administration (FDA) [ ...

Emerging biomarkers in the diagnosis of prostate cancer

New promising biomarkers, such as PSA glycoforms, TMPRSS2:ERG fusion gene, microRNAs, circulating tumor cells, androgen receptor variants, ...

Emerging biomarkers in the detection and prognosis of prostate ...

The prostate-specific antigen (PSA) is currently the most used tumor marker in the early detection of the prostate cancer (PCa), ...